Jill Feldman discusses the background of the phase 2 COCOON trial in advanced non–small cell lung cancer with EGFR mutations.

A scientific team has unlocked a new way to treat serious lung conditions by using specially designed nanoparticles to ...

EGFR inhibitors such as Erbitux and Gilotrif show potential in laboratory and mouse studies in treating melanoma with a ...

Increased activity in a specific biological pathway may explain why many patients with a deadly form of skin cancer do not ...

In mice, engineered immune cells shrink pancreatic and other tumours bearing a mutant version of the KRAS protein.

Dr. Suresh Ramalingam discusses how Tagrisso has ushered in a new era of care for patients with advanced EGFR+ non-small cell ...

Increased activity in a specific biological pathway may explain why many patients with a deadly form of skin cancer do not ...

ASCO Data Shows New Therapy Extends Survival in Small Cell Lung Cancer. Here's what you need to know about the new ...

Using a 14-gene test to guide chemotherapy significantly improved disease-free survival in patients with early nonsquamous ...

Background Prior work suggests different interstitial lung diseases (ILDs) that share the radiological usual interstitial pneumonia (UIP) pattern have an overall worse prognosis. However, ...